Targeting mTOR to Overcome Resistance to Hormone and CDK4/6 Inhibitors in ER-Positive Breast Cancer Models

Scientists assessed the mechanisms of acquired resistance using T47D and MCF-7 tamoxifen- and palbociclib-resistant cell-line variants in culture and as xenografts, and patient-derived cells obtained from sensitive or resistant patient-derived xenografts.